key: cord-0265518-bw5jfasc authors: Maina, D.; Omuse, G.; Ong'ete, G.; Mugaine, P.; Sayed, S.; Moloo, Z.; Shah, R.; Etyang, A.; Adam, R. title: Seroprevalence, correlates and kinetics of SARS-CoV-2 Nucleocapsid IgG antibody in healthcare workers at a tertiary hospital: a prevaccine census study date: 2022-04-16 journal: nan DOI: 10.1101/2022.04.13.22273817 sha: 10845edfc776fe53750f1585e863bbe50a311f4c doc_id: 265518 cord_uid: bw5jfasc Background: Healthcare workers are perceived to be a high-risk group for acquiring SAR-CoV-2 infection, and more so in countries where COVID-19 vaccination uptake is low. Serosurveillance may best determine the true extent of SARS-CoV-2 infection since most infected HCWs may be asymptomatic or present with only mild symptoms. Over time, determining the true extent of SARS-CoV-2 infection could inform hospital management and staff whether the preventive measures instituted are effective and valuable in developing targeted solutions. Methods: This was a census survey study conducted at the Aga Khan University Hospital, Nairobi, between November 2020 and February 2021 before the implementation of the COVID-19 vaccination. The SARS-CoV-2 nucleocapsid IgG test was performed using a chemiluminescent assay. Results: One thousand six hundred thirty-one (1631) staff enrolled, totalling 60% of the workforce. The overall crude seroprevalence was 18.4% and the adjusted (for assay sensitivity of 86%) was 21.4% (95% CI; 19.2-23.7). The HCW groups with higher prevalence included pharmacy (25.6%), outreach (24%), hospital- based nursing (22.2%) and catering staff (22.6%). Independent predictors of a positive IgG result included prior COVID-19 like symptoms, odds ratio (OR) 1.9 [95% confidence interval (CI) 1.3-2.9, p=0.002]; a prior positive SARS-CoV-2 PCR result OR 11.7 (CI: 7.5-18.1, p<0.001) and working in a designated clinical COVID-19 location (high risk), OR 1.8 (CI: 1.04-3.11, p=0.033). Age, sex or comorbidities were not associated with seropositivity. The odds of testing positive for IgG after a positive PCR test were lowest if the antibody test was performed more than 2 months later OR 0.7 (CI: 0.48-0.95, p= 0.025). Conclusions: The prevalence of anti- SARS-CoV-2 nucleocapsid IgG among HCWs was lower than in the general population. Staff working in clinical areas were not at increased risk when compared to staff working in non-clinical areas. Conclusions: The prevalence of anti-SARS-CoV-2 nucleocapsid IgG among HCWs was lower 48 than in the general population. Staff working in clinical areas were not at increased risk when 49 compared to staff working in non-clinical areas. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. implemented. Therefore, we wished to know the level of risk to HCWs where PPE and testing 78 are readily available. 79 Although liberal PCR testing of HCWs has been done at AKUHN throughout the 80 outbreak, asymptomatic HCWs were not routinely tested. Since asymptomatic infections have 81 comprised a significant percentage of infections in some series, it is possible that a significant . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) A phlebotomist collected 5-10 ml of blood in a serum separator vacutainer (Greiner Bio-102 One GmbH -Germany) from each participant. In all cases, blood samples were labelled with a 103 unique study identifier, centrifuged and serum separated within 24 hours of collection. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 16, 2022. ; https://doi.org/10.1101/2022.04.13.22273817 doi: medRxiv preprint 127 Risks (associations) were analysed using logistic regression analyses and chi-square 128 statistics, presented here, respectively, as odds ratio (OR) with 95% confidence interval (95% CI) 129 and chi statistics with p-value. Table 1 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 16, 2022. ; https://doi.org/10.1101/2022.04.13.22273817 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 16, 2022. ; https://doi.org/10.1101/2022.04.13.22273817 doi: medRxiv preprint The seroprevalence in participants who tested positive for SARS-CoV-2 by PCR peaked 1- Elsewhere on the continent, seroprevalence among HCW ranged from 0% to 45.1%, 218 with the highest prevalence in Nigeria (7). 219 Contrary to previous assumptions, there was no significant difference in seroprevalence 220 between frontline staff (high-risk work-based exposure) and staff working in nonclinical areas 221 (low-risk work exposure), suggesting that most of the SARS-CoV-2 infections occurred in the 222 community. During the same period, a study conducted in India reported similar figures 223 between HCWs and the general public (25.6% versus 23.2%) (8). Here in Kenya, a study 224 reported a higher prevalence (61.8%) among blood donors than the prevailing seroprevalence 225 among HCWs in Nairobi for the period January through March 2021(9), reflecting the high 226 community transmission prevalent during the study period. 227 The seroprevalence across the age groups was similar for HCW under 60 years of age 228 and then decreased for age ≥60. Some studies have found increased seropositivity with 229 increasing age for some age brackets (10, 11). Pharmacy and catering staff had the highest . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Symptomatic staff had mild COVID-19 disease, none of which required hospitalisation. 238 The hospital workforce is relatively young (mean age of 37 years) and has few comorbidities, 239 which could partly explain the mild COVID-19 disease seen in the facility. All participants in our study had mild disease or were asymptomatic and the kinetics 249 described here may not apply to those with severe COVID-19 disease, which has been 250 associated with earlier and higher antibody levels compared with asymptomatic infections (16, 251 17). . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 16, 2022. ; https://doi.org/10.1101/2022.04.13.22273817 doi: medRxiv preprint There were no statistically significant differences in 256 seroprevalence between the clinical areas and the rest of the hospital. Independent predictors 257 of a seropositive result were a positive SARS-CoV-2 PCR result and flu-like symptoms in the 3 258 months prior to joining the study Much appreciation to the administration of AKUHN for facilitating the study. Thanks to Cyrus Matheka David Kawalya and Assumpta Chege for the logistical assistance COVID-19) Vaccinations Seroprevalence of Antibodies 270 to Severe Acute Respiratory Syndrome Coronavirus 2 Among Healthcare Workers in Kenya. Clinical 271 Infectious Diseases COVID-19 WHO African Region: External situation report 12 Screening of healthcare 274 workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission Evaluation of the Abbott SARS-CoV-2 IgG for the detection of anti-SARSCoV-2 277 antibodies Adjusting coronavirus prevalence estimates for laboratory test kit error. 279 American journal of epidemiology Seroprevalence and Risk Factors of COVID-19 in 281 Healthcare Workers From Eleven African Countries: A Scoping Review and Appraisal of Existing 282 Evidence. Health policy and planning CoV-2 seroprevalence among the general population and healthcare workers in India Prevalence of SARS-CoV-2 287 antibodies from a national serosurveillance of Kenyan blood donors SARS-CoV-2 seroconversion 290 among 4040 Egyptian healthcare workers in 12 resource-limited healthcare facilities: A prospective 291 cohort study SARS-CoV2 IgG antibody: 293 Seroprevalence among health care workers. Clinical epidemiology and global health Symptoms in health care workers during the COVID-19 296 epidemic. A cross-sectional survey. International journal of environmental research and public 297 health COVID-19 and healthcare 299 workers: A systematic review and meta-analysis Longitudinal follow-302 up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after 303 infection Long-term 305 specific IgG response to SARS-CoV-2 nucleocapsid protein in recovered COVID-19 patients Antibody responses to SARS-CoV-2 in patients of 308 novel coronavirus disease 2019 Different longitudinal patterns of nucleic acid 310 and serology testing results based on disease severity of COVID-19 patients. Emerging microbes & 311 infections